| Literature DB >> 35077937 |
Lenin González-Paz1, María José Alvarado2, María Laura Hurtado-León2, Carla Lossada3, Joan Vera-Villalobos4, Marcos Loroño5, J L Paz6, Laura N Jeffreys7, F Javier Torres8, Ysaias J Alvarado9.
Abstract
Cellular susceptibility to SARS-CoV-2 infection in the respiratory tract has been associated with the ability of the virus to interact with potential receptors on the host membrane. We have modeled viral dynamics by simulating various cellular systems and artificial conditions, including macromolecular crowding, based on experimental and transcriptomic data to infer parameters associated with viral growth and predict cell susceptibility. We have accomplished this based on the type, number and level of expression of the angiotensin-converting enzyme 2 (ACE2), transmembrane serine 2 (TMPRSS2), basigin2 (CD147), FURIN protease, neuropilin 1 (NRP1) or other less studied candidate receptors such as heat shock protein A5 (HSPA5) and angiotensin II receptor type 2 (AGTR2). In parallel, we studied the effect of simulated artificial environments on the accessibility to said proposed receptors. In addition, viral kinetic behavior dependent on the degree of cellular susceptibility was predicted. The latter was observed to be more influenced by the type of proteins and expression level, than by the number of potential proteins associated with the SARS CoV-2 infection. We predict a greater theoretical propensity to susceptibility in cell lines such as NTERA-2, SCLC-21H, HepG2 and Vero6, and a lower theoretical propensity in lines such as CaLu3, RT4, HEK293, A549 and U-251MG. An important relationship was observed between expression levels, protein diffusivity, and thermodynamically favorable interactions between host proteins and the viral spike, suggesting potential sites of early infection other than the lungs. This research is expected to stimulate future quantitative experiments and promote systematic investigation of the effect of crowding presented here.Entities:
Keywords: Cell lines; Cell susceptibility; Docking; Macromolecular crowding; Viral spike
Mesh:
Year: 2022 PMID: 35077937 PMCID: PMC8770263 DOI: 10.1016/j.compbiomed.2022.105245
Source DB: PubMed Journal: Comput Biol Med ISSN: 0010-4825 Impact factor: 4.589
Profile of the proposed theoretical expression systems.
| System | Cell lines | Individual Expression | |
|---|---|---|---|
| 1 | Vero6 | NRP1 (A), CD147 (B), FURIN (C), TMPRSS2 (D), | |
| 2 | A549 | ||
| 3 | HepG2 | ||
| 4 | CaCo2 | ||
| 5 | HEK293 | ||
| 6 | HeLa | ||
| 7 | U251 MG | ||
| 8 | CaLu3 | ||
| 9 | NTERA-2 | ||
| 10 | RPTEC TERT1 | ||
| 11 | RT4 | ||
| 12 | HBEC3-KT | ||
| 13 | SCLC-21H | ||
| System | Multiple Expression | ||
| 14 | NRP1+CD147+FURIN + TMPRSS2+ACE2+HSPA5+AGTR2 | Vero6 (A), A549 (B), | |
| 15 | TMPRSS2+ACE2 | ||
| 16 | NRP1+CD147+FURIN + TMPRSS2+ACE2 | ||
| 17 | NRP1+FURIN + TMPRSS2+ACE2 | ||
| 18 | CD147+FURIN + TMPRSS2+ACE2 | ||
| 19 | NRP1+CD147+TMPRSS2+ACE2 | ||
| 20 | FURIN + TMPRSS2+ACE2 | ||
| 21 | NRP1+TMPRSS2+ACE2 | ||
| 22 | CD147+TMPRSS2+ACE2 | ||
| 23 | CD147+TMPRSS2 | ||
| 24 | HSPA5+AGTR2 | ||
| 25 | HSPA5+AGTR2+TMPRSS2+ACE2 | ||
Angiotensin converting enzyme 2 (ACE2), transmembrane serine 2 (TMPRSS2), basigin2 (CD147), FURIN protease, neuropilin 1 (NRP1), heat shock proteinA5 (HSPA5) and angiotensin II receptor type 2 (AGTR2).
Fig. 1Cell lines and the level of RNA expression of the potential receptors considered in this study in terms of normalized NX values. The expression levels of angiotensin converting enzyme 2 (ACE2), transmembrane serine 2 (TMPRSS2), basigin2 (CD147), FURIN protease, neuropilin 1 (NRP1), heat shock protein A5 (HSPA5) and angiotensin II receptor type 2 (AGTR2), are shown.
Fig. 2Summary of the RNA expression levels of the receptors studied in different cell lines analyzed in the Atlas of Human Proteins. The generated RNA sequencing results are reported as normalized NX values. Numerical values and a pie chart representation of the expression levels of angiotensin converting enzyme 2 (ACE2), transmembrane serine 2 (TMPRSS2), basigin2 (CD147), FURIN protease, neuropilin 1 (NRP1), heat shock protein A5 (HSPA5) and angiotensin II receptor type 2 (AGTR2).
Fig. 3Proteins associated with SARS-CoV-2 infection with correlation between their levels of consensus normalized expression (NX). A) moderate positive correlation between the receptor ACE2 and TMPRSS2 protease (r = 0.60), and B) moderate negative correlation between CD147 protein and TMPRSS2 (r = 0.70).
Estimates of the number of susceptible cells (U), dead infected cells (δ), productive release rate of virions from cells (p) and basic reproduction number (R).
| System(s) | ||||
|---|---|---|---|---|
| 1 (A-G) | 1.9 x104 [1.0 x101 - 7.3 x104] | 4.4 x105 [2.3 x102 - 1.7 x106] | 2.1 x104 [1.4 x101 - 7.6 x104] | 19.1 ± 3.8 |
| 2 (A-G) | 2.2 x104 [1.0 x101 - 8.6 x104] | 4.9 x105 [2.3 x102 - 1.9 x106] | 2.3 x104 [1.4 x101 - 8.9 x104] | 16.7 ± 5.5 |
| 3 (A-G) | 2.7 x104 [1.0 x101 - 9.2 x104] | 6.1 x105 [2.3 x102 - 2.1 x106] | 2.8 x104 [1.4 x101 - 9.5 x104] | 19.2 ± 3.8 |
| 4 (A-G) | 2.0 x104 [1.0 x101 - 6.8 x104] | 4.4 x105 [2.3 x102 - 1.5 x106] | 2.1 x104 [1.4 x101 - 7.1 x104] | 18.0 ± 4.9 |
| 5 (A-G) | 1.7 x104 [1.0 x101 - 8.9 x104] | 3.8 x105 [2.3 x102 - 2.0 x106] | 1.7 x104 [1.4 x101 - 9.2 x104] | 17.6 ± 4.7 |
| 6 (A-G) | 1.7 x104 [1.0 x101 - 7.2 x104] | 4.0 x105 [2.3 x102 - 1.6 x106] | 1.8 x104 [1.4 x101 - 7.5 x104] | 16.6 ± 5.4 |
| 7 (A-G) | 2.3 x104 [1.0 x101 - 8.0 x104] | 5.2 x105 [2.3 x102 - 1.8 x106] | 2.4 x104 [1.4 x101 - 8.3 x104] | 16.8 ± 5.6 |
| 8 (A-G) | 2.2 x104 [1.0 x101 - 8.6 x104] | 4.9 x105 [2.3 x102 - 1.9 x106] | 2.3 x104 [1.4 x101 - 8.9 x104] | 16.7 ± 5.5 |
| 9 (A-G) | 2.0 x104 [1.0 x101 - 9.6 x104] | 4.6 x105 [2.3 x102 - 2.2 x106] | 2.1 x104 [1.4 x101 - 9.9 x104] | 18.7 ± 3.7 |
| 10 (A-G) | 2.2 x104 [1.0 x101 - 7.5 x104] | 4.9 x105 [2.3 x102 - 1.7 x106] | 2.3 x104 [1.4 x101 - 7.8 x104] | 18.9 ± 3.8 |
| 11 (A-G) | 1.7 x104 [1.0 x101 - 4.8 x104] | 3.9 x105 [2.3 x102 - 1.1 x106] | 1.8 x104 [1.4 x101 - 5.0 x104] | 19.1 ± 3.8 |
| 12 (A-G) | 1.9 x104 [1.0 x101 - 6.4 x104] | 4.3 x105 [2.3 x102 - 1.5 x106] | 2.0 x104 [1.4 x101 - 6.7 x104] | 18.6 ± 5.7 |
| 13 (A-G) | 1.2 x104 [1.0 x101 - 6.3 x104] | 2.7 x105 [2.3 x102 - 1.4 x106] | 1.3 x104 [1.4 x101 - 6.6 x104] | 18.3 ± 5.6 |
| 14 (A-M) | 2.0 x104 [1.2 x104 - 2.7 x104] | 4.5 x105 [2.7 x105 - 6.1 x105] | 2.1 x104 [1.3 x104 - 2.9 x104] | 20.9 ± 0.1 |
| 15 (A-M) | 2.9 x103 [1.0 x101 - 1.8 x104] | 6.5 x104 [2.3 x102 - 4.1 x105] | 3.2 x103 [1.4 x101 - 2.0 x104] | 16.7 ± 4.1 |
| 16 (A-M) | 2.1 x104 [1.4 x104 - 2.6 x104] | 4.7 x105 [3.1 x105 - 5.9 x105] | 2.3 x104 [1.5 x104 - 2.8 x104] | 20.9 ± 0.1 |
| 17 (A-M) | 6.8 x103 [1.2 x103 - 1.3 x104] | 1.5 x105 [2.4 x104 - 2.8 x105] | 7.6 x103 [1.4 x103 - 1.4 x104] | 20.0 ± 0.5 |
| 18 (A-M) | 2.3 x104 [1.7 x104 - 2.8 x104] | 5.3 x105 [3.9 x105 - 6.4 x105] | 2.5 x104 [1.9 x104 - 3.0 x104] | 21.0 ± 0.1 |
| 19 (A-M) | 2.3 x104 [1.6 x104 - 3.0 x104] | 5.2 x105 [3.6 x105 - 6.8 x105] | 2.5 x104 [1.9 x104 - 3.0 x104] | 20.6 ± 2.8 |
| 20 (A-M) | 5.7 x103 [1.5 x103 - 1.6 x104] | 1.3 x105 [3.5 x104 - 3.6 x105] | 3.3 x103 [9.2 x102 - 8.8 x103] | 19.0 ± 0.8 |
| 21 (A-M) | 5.2 x103 [4.0 x101 - 1.2 x104] | 1.2 x105 [9.1 x102 - 2.8 x105] | 3.0 x103 [2.7 x101 - 6.9 x103] | 17.9 ± 2.9 |
| 22 (A-M) | 2.7 x104 [2.1 x104 - 3.2 x104] | 6.2 x105 [4.8 x105 - 7.3 x105] | 1.5 x104 [1.2 x104 - 1.8 x104] | 21.2 ± 0.2 |
| 23 (A-M) | 4.1 x104 [3.2 x104 - 4.9 x104] | 9.2 x105 [7.2 x105 - 1.1 x106] | 2.2 x104 [1.7 x104 - 2.6 x104] | 21.4 ± 1.5 |
| 24 (A-M) | 1.7 x104 [7.2 x103 - 3.4 x104] | 3.8 x105 [1.6 x105 - 7.6 x105] | 9.4 x103 [4.1 x103 - 1.8 x104] | 20.5 ± 0.6 |
| 25 (A-M) | 9.8 x103 [3.6 x103 - 1.8 x104] | 2.2 x104 [8.2 x104 - 4.1 x105] | 5.6 x104 [2.1 x103 - 1.0 x104] | 19.8 ± 0.6 |
The mean, minimum and maximum values of the simulated expression systems are shown, *, The mean and standard deviation values are displayed.
Fig. 4Mechanistic model of the estimates of the rates of uninfected cells (U), infected cells (I) and death of infected cells (δ). For illustrative purposes, only a representative graph of the individual expression systems cited in the text is shown for each cell line studied using the limited target cell model. Additional graphics are shown in supplementary material. A) Individual expression of CD147 in the HepG2 cell line (3-B system), B) individual expression of FURIN in the SCLC-21H cell line (13-D system), C) individual expression of CD147 in the NTERA-2 cell line (9-B system), D) individual expression of AGTR2 in the Vero6 cell line (1-G system), E) Individual expression of AGTR2 in the RPTEC TERT1 cell line (10-G system), F) individual expression of AGTR2 in cell line RT4 (11-G system), G) Individual expression of ACE2 in the CaCo2 cell line (4-E system), H) individual expression of TMPRSS2 in the A549 cell line (2-D system), I) individual expression of TMPRSS2 in the HEK293 cell line (5-D system), J) individual expression of AGTR2 in the U251 MG cell line (7-G system), K) individual expression of AGTR2 in the CaLu3 cell line (8-G system), L) individual expression of AGTR2 in the HBEC3-KT cell line (12-G system).
Comparative analysis of the relative macromolecular binding affinity of the spike and each of its domains (S1 and S2) with each of the proteins of interest using different docking methods and scoring functions.
| Protein | PDB | HDOCK (kcal/mol) | MM/GBSA (kcal/mol)* | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Spike (Open) | Spike (Close) | S1 | S2 | Spike (Open) | Spike (Close) | S1 | S2 | ||
| NRP1 | 7JJC | −274.84 | −277.27 | −269.17 | −244.32 | −61.81 | −37.79 | −53.60 | −35.93 |
| CD147 | 3I84 | −218.99 | −244.20 | −210.55 | −183.22 | −46.47 | −45.17 | −46.57 | −27.40 |
| FURIN | 6HZB | −290.38 | −289.39 | −292.35 | −251.20 | −49.54 | −39.84 | −44.43 | −37.58 |
| TMPRSS2 | 7MEQ | −341.26 | −331.70 | −267.71 | −262.47 | −31.83 | −36.36 | −49.94 | −47.19 |
| ACE2 | 6VW1 | −304.94 | −269.98 | −352.45 | −249.45 | −21.90 | −24.18 | −49.53 | −28.02 |
| HSPA5 | 6ZYH | −266.58 | −270.19 | −233.86 | −208.61 | −40.04 | −35.80 | −29.75 | −25.32 |
| AGTR2 | 6JOD | −446.61 | −366.70 | −351.16 | −357.21 | −63.71 | −60.49 | −39.26 | −68.29 |
For the spike protein, the open (PDB: 6VYB) and closed (PDB: 6VXX) conformations of the structure are considered; *, For the energy calculation with the molecular mechanics approach combined with generalized Born calculations and continuous surface area solvation (MM/GBSA) calculations to predict the binding free energy of the protein-protein complex per residue, the HawkDock web server was used.
Comparative analysis of the residues called hot spots in the relative macromolecular junction of the spike domains (S1 and S2) with each of the proteins of interest.
| PDB | Spike | |||||||
|---|---|---|---|---|---|---|---|---|
| NRP1 ( | CD147 ( | FURIN ( | TMPRSS2 ( | ACE2 ( | HSPA5 ( | AGTR2 ( | ||
| 7DEO | S1 | Glu16(A), Glu21(A), Glu24(A), Glu43(A), Glu51(A), Asp128(A)/Glu340(B), Glu471(B), Glu484(B) | Glu340(A), Glu516(A)/Glu49(B), Glu64(B), Glu84(B), Glu92(B) | Asp23(A), Asp284(A), Asp322(A)/Asp405(B), Glu406(B) | Glu289(B), Glu329(B), Asp359(B), Asp491(B)/Asp405(A), Glu406(A), Asp420(A), Glu484(A) | Asp118(A), Glu122(A), Glu132(A), Asp139(A), Glu142(A), Asp274(A), Asp277(A), Asp281(A), Asp285(A), Asp317(A)/Glu340(B), Asp442(B), Glu465(B), Asp467(B), Glu471(B), GLU484(B) | Glu44(A), Glu46(A), Glu116(A), Glu117(A), Glu128(A), Glu131(A), Asp159(A)/Glu471(B), Glu484(B) | Glu340(B) |
| NRP1 ( | CD147 ( | FURIN ( | TMPRSS2 ( | ACE2 ( | HSPA5 ( | AGTR2 ( | ||
| 7COT | S2 | Glu58(A), Asp59(A), Glu113(A), Glu151(A)/Glu106(B) | Glu119(A), Asp123(A)/Asp32(B), Glu84(B), Glu92(B) | Asp430(B) | Glu406(B), Asp482(B)/Asp27(A), Glu106(A) | Asp195(A), Glu417(A), Glu509(A), Glu518(A), Glu553(A), Glu571(A)/Asp70(B) | Glu89(B), Glu121(B), Asp131(B), Asp281(B), Glu314(B)/Asp70(A), Asp92(A) | Glu257(A)/Asp92(B), Glu106(B) |
Only the residues present at the interface are shown that represent most of the binding free energy (hot spots) in the protein-protein complex according to the KFC (Knowledge-based FADE and Contacts) model. n (total number of residues at the interface (number of S domain residues/number of receptor type residues), including “no hot spots” residues).
Fig. 5Graphic representation of the interface between the residues called hot spots in the relative macromolecular junction of the spike S1 domain with each of the proteins of interest. A) Neuropilin 1 (NRP1), B) Basigin2 (CD147), C) FURIN protease, D) Transmembrane serine 2 (TMPRSS2), E) Angiotensin converting enzyme 2 (ACE2), F) Heat shock protein A5 (HSPA5) and G) angiotensin II receptor type 2 (AGTR2). Only the residues present at the interface are shown that represent most of the binding free energy in the protein-protein complex according to the KFC (Knowledge-based FADE and Contacts) model.
Fig. 6Graphic representation of the interface between the residues called hot spots in the relative macromolecular junction of the spike S2 domain with each of the proteins of interest. A) Neuropilin 1 (NRP1), B) Basigin2 (CD147), C) FURIN protease, D) Transmembrane serine 2 (TMPRSS2), E) Angiotensin converting enzyme 2 (ACE2), F) Heat shock protein A5 (HSPA5) and G) angiotensin II receptor type 2 (AGTR2). Only the residues present at the interface are shown that represent most of the binding free energy in the protein-protein complex according to the KFC (Knowledge-based FADE and Contacts) model.
Fig. 7The mean squared deviations (RMSD) of Cα during each 10ns of MD simulation for each complex (total time 100ns). A) NRP1, B) CD147, C) FURIN, D) TMPRSS2, E) ACE2, F) HSPA5 and G) AGTR2. The gray lines represent the free receptor proteins, and the blue and orange lines the complexes with the S1 and S2 region, respectively.
Fig. 8The root mean square deviations (RMSD) of Cα and root mean square fluctuations (RMSF) of individual amino acid residues relative to the starting frame during 100ns MD simulation of each complex using NMSim. NRP1 (A and B), CD147 (C and D), FURIN (E and F), TMPRSS2 (G and H), ACE2 (I and J), HSPA5 (K and L), AGTR2 (M and N). The gray lines represent the free receptor proteins, and the blue and orange lines the complexes with the S1 and S2 region, respectively.
Comparative analysis of the theoretical translational diffusion coefficient and the diffusion time of the proteins of interest associated with cellular susceptibility in SARS-CoV-2 infection.
| MW (kDa) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | Model 4 | Model 5 | Model 6 | ||||
| NRP1 | 79.20 | 15.33 | 1.0x10−26 | 3.2x10−22 | 5.8x10−22 | 8.6x10−21 | 1.3x10−25 | 6.3x10−11 | 13.2 |
| CD147 | 21.15 | 16.06 | 9.6x10−27 | 3.0x10−22 | 5.6x10−22 | 8.2x10−21 | 1.2x10−25 | 8.3x10−11 | 10.0 |
| FURIN | 53.70 | 21.78 | 7.1x10−27 | 2.2x10−22 | 4.1x10−22 | 6.0x10−21 | 8.9x10−26 | 7.1x10−11 | 11.7 |
| TMPRSS2 | 44.50 | 20.28 | 7.6x10−27 | 2.4x10−22 | 4.4x10−22 | 6.5x10−21 | 9.6x10−26 | 7.5x10−11 | 11.2 |
| ACE2 | 192.75 | 24.29 | 6.4x10−27 | 2.0x10−22 | 3.7x10−22 | 5.4x10−21 | 8.0x10−26 | 4.6x10−11 | 18.0 |
| HSPA5 | 84.75 | 21.38 | 7.2x10−27 | 2.3x10−22 | 4.2x10−22 | 6.2x10−21 | 9.1x10−26 | 6.0x10−11 | 13.8 |
| AGTR2 | 92.57 | 21.94 | 7.0x10−27 | 2.2x10−22 | 4.1x10−22 | 6.0x10−21 | 8.9x10−26 | 5.6x10−11 | 14.8 |
Dt, translational diffusion coefficient. Neuropilin 1 (NRP1), Basigin2 (CD147), FURIN protease, Transmembrane Serine 2 (TMPRSS2), Angiotensin Converting Enzyme 2 (ACE2), Protein of Thermal shock A5 (HSPA5), Angiotensin II receptor type 2 (AGTR2). Model 1, A549 (∼4.4x10−2 Pa/s) [27]; Model 2, HeLa negative control (∼4.4x10−2 Pa/s) [27]; Model 3, Normal Swiss 3T3 cells (∼2.4x10−2 Pa/s) [27,28]; Model 4, ASTC-a-1 (∼1.6x10−3 Pa/s) [29]; Model 5, H1299 (∼1.1x102 Pa/s) [30]; Model 6, standard viscosity of water (∼1.0x10−3 Pa/s) [56]. *, time calculated in model 6.
Comparative analysis of the theoretical transmembrane flux of the proteins of interest associated with cellular susceptibility in SARS-CoV-2 infection.
| Protein | |||||
|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | Model 4 | Model 5 | |
| NRP1 | 6.7x10−21 | 2.1x10−16 | 3.9x10−16 | 5.7x10−15 | 8.5x10−20 |
| CD147 | 6.4x10−21 | 2.0x10−16 | 3.7x10−16 | 5.5x10−15 | 8.1x10−20 |
| FURIN | 4.7x10−21 | 1.5x10−16 | 2.7x10−16 | 4.0x10−15 | 6.0x10−20 |
| TMPRSS2 | 5.1x10−21 | 1.6x10−16 | 2.9x10−16 | 4.3x10−15 | 6.4x10−20 |
| ACE2 | 4.2x10−21 | 1.3x10−16 | 2.5x10−16 | 3.6x10−15 | 5.3x10−20 |
| HSPA5 | 4.8x10−21 | 1.5x10−16 | 2.8x10−16 | 4.1x10−15 | 6.1x10−20 |
| AGTR2 | 4.7x10−21 | 1.5x10−16 | 2.7x10−16 | 4.0x10−15 | 5.9x10−20 |
J, diffusion flow. Neuropilin 1 (NRP1), Basigin2 (CD147), Protease FURIN, Transmembrane Serine 2 (TMPRSS2), Angiotensin Converting Enzyme 2 (ACE2), Protein of Thermal shock A5 (HSPA5), Angiotensin II receptor type 2 (AGTR2). Model 1, A549 (∼4.4x10−2 Pa/s) [27]; Model 2, HeLa negative control (∼4.4x10−2 Pa/s) [27]; Model 3, Normal Swiss 3T3 cells (∼2.4x10−2 Pa/s) [27,28]; Model 4, ASTC-a-1 (∼1.6x10−3 Pa/s) [29]; Model 5, H1299 (∼1.1x102 Pa/s) [30].